Biltricide Tablet, Film Coated
Product Images NDC 50419-747

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Biltricide (NDC 50419-747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600 mg Label (34ce1cdd 648e 4f1e 8512 Bf3d4cc22eb9 02)

Biltricide 600 mg tablets (praziquantel) film-coated oral tablets, package contains 6 tablets. Label shows Bayer HealthCare Pharmaceuticals Inc. as the manufacturer with product NDC 50419-747-01, and includes dosage details and storage instructions.*

FDA Label Image

Image 01

Chemical structure diagram of praziquantel, the active ingredient in Biltricide 600 mg oral film-coated tablets. The structure shows the molecular arrangement including rings and functional groups characteristic of praziquantel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.